Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX)
CUSIP: M40527109
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Ordinary shares, par value NIS 0.0000769 per share
- Shares outstanding
- 45,504,462
- Total 13F shares
- 4,916,394
- Share change
- -32,934
- Total reported value
- $6,538,000
- Price per share
- $1.33
- Number of holders
- 9
- Value change
- -$45,964
- Number of buys
- 1
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP M40527109?
CUSIP M40527109 identifies ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP M40527109:
Top shareholders of ENTX - Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Knoll Capital Management, LLC |
13F
|
Company |
5.5%
|
2,484,275
|
$7,130,000 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.2%
|
2,353,000
|
$6,753,000 | — | 31 Mar 2022 | |
| Phillip Schwartz |
3/4/5
|
President of R&D, Director |
—
class O/S missing
|
607,410
|
$601,336 | — | 20 Jan 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
46,209
|
$132,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
17,597
|
$50,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
15,057
|
$43,000 | — | 31 Mar 2022 | |
| Altium Wealth Management LLC |
13F
|
Company |
0.03%
|
11,830
|
$34,000 | — | 31 Mar 2022 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
10,000
|
$29,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,956
|
$14,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
4,660
|
$13,000 | — | 31 Mar 2022 | |
| Ramesh Ratan |
3/4/5
|
U.S.based CFO |
—
class O/S missing
|
10,000
|
$9,900 | — | 19 Jan 2022 | |
| Spiros Jamas |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
10,000
|
$9,900 | — | 18 Jan 2022 | |
| ARK Investment Management LLC |
13F
|
Company |
0%
|
1,744
|
$5,000 | — | 31 Mar 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
581
|
$2,000 | — | 31 Mar 2022 |
Institutional Holders of Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) as of Q2 2022
As of 30 Jun 2022,
Entera Bio Ltd. - Ordinary shares, par value NIS 0.0000769 per share (ENTX) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,916,394 shares.
The largest 9 holders included
Knoll Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, Altium Wealth Management LLC, PNC Financial Services Group, Inc., UBS Group AG, and MORGAN STANLEY.
This page lists
9
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
10
Q2 2022 holders
9
Holder diff
-1
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.